Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries
Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
Cosmos Health secures a 3-year contract manufacturing agreement for 3.9 million units of VASCLOR GEST progesterone pessaries.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.